2nd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference
In-Person Event
May 21 - 22, 2018
London, England, GB
OVERVIEW
2nd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference is organized by SMi Group and will be held during May 21 - 22, 2018 at Holiday Inn Kensington Forum, London, England, United Kingdom.
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs.
However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.
This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find new innovative solutions.
Featured Highlights :
• Discover practical approaches to HPAPI manufacturing in a controlled and efficient manner
• Explore different containment methods and learn about which strategy best suits your needs
• Evaluate the use of containment risk mitigation tools in early phase development
• Learn how to manage and effectively and safely dispose of HPAPI, post-production waste
• Discuss the most important regulations surrounding potent ingredients.
Benifits of Attending :
• Learn how to reduce HPAPI manufacturing costs and get the best value for your money without cutting back on the importance of safety and containment procedures.
• Network with industry fellows and hear about new developments, innovation and challenges in areas such as cross-contamination, manufacturing efficiency, safety practices, outsourcing strategies, compound development and manufacturing, etc.
• Hear about the HPAPI market development, reasons why it’s growing so rapidly and how to benefit from this, as well as why the HPAPI demand is still higher than the supply despite there being various suppliers involved in the industry.
• Experience an information-packed learning environment, designed to provide you with the best insight into new innovation in the HPAPI sector, leaving you well prepared for the challenges you’re currently facing.
Key Speakers Include :
Ildiko Zeigler, Validation Expert, Gedeon Richter
Ulrich Ruemenapp, Head of Launch Preparation and Coordination, Bayer
Vincenzo De Sio, HPAPI Specialist, Cristalia
Pascal Drago, Principal Technical Manager, Roche
Henri Motte, Head of Pilot Plant, UCB Pharma
Jeff Parry, Senior Scientist Manufacturability, AstraZeneca
Greg Sowell, Principal Scientific Manager, Genentech
Price:
Standard Price (early-bird rates available): GBP 1499.
Additional details will be posted as soon as they are available.
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs.
However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions.
This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find new innovative solutions.
Featured Highlights :
• Discover practical approaches to HPAPI manufacturing in a controlled and efficient manner
• Explore different containment methods and learn about which strategy best suits your needs
• Evaluate the use of containment risk mitigation tools in early phase development
• Learn how to manage and effectively and safely dispose of HPAPI, post-production waste
• Discuss the most important regulations surrounding potent ingredients.
Benifits of Attending :
• Learn how to reduce HPAPI manufacturing costs and get the best value for your money without cutting back on the importance of safety and containment procedures.
• Network with industry fellows and hear about new developments, innovation and challenges in areas such as cross-contamination, manufacturing efficiency, safety practices, outsourcing strategies, compound development and manufacturing, etc.
• Hear about the HPAPI market development, reasons why it’s growing so rapidly and how to benefit from this, as well as why the HPAPI demand is still higher than the supply despite there being various suppliers involved in the industry.
• Experience an information-packed learning environment, designed to provide you with the best insight into new innovation in the HPAPI sector, leaving you well prepared for the challenges you’re currently facing.
Key Speakers Include :
Ildiko Zeigler, Validation Expert, Gedeon Richter
Ulrich Ruemenapp, Head of Launch Preparation and Coordination, Bayer
Vincenzo De Sio, HPAPI Specialist, Cristalia
Pascal Drago, Principal Technical Manager, Roche
Henri Motte, Head of Pilot Plant, UCB Pharma
Jeff Parry, Senior Scientist Manufacturability, AstraZeneca
Greg Sowell, Principal Scientific Manager, Genentech
Price:
Standard Price (early-bird rates available): GBP 1499.
Additional details will be posted as soon as they are available.
KEY DATES
21 May, 2018
Event Start Date
22 May, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Holiday Inn Kensington ForumRELATED CONFERENCES & LIVE WEBINARS
Quick Links